Cycliq Group Limited (ASX:CYQ)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2	1	2	3	10	1
Market Cap Growth	114.68%	-48.56%	-40.00%	-64.08%	662.49%	92.78%
Enterprise Value	1	0	1	2	9	1
Last Close Price	0.00	0.00	0.01	0.01	0.03	0.01
PS Ratio	0.36	0.23	0.40	0.74	2.71	0.33
PB Ratio	8.60	-89.53	2.71	3.20	7.48	-2.03
P/TBV Ratio	-	-	2.63	3.08	6.94	-
P/FCF Ratio	5.84	-	4.47	-	-	3.94
P/OCF Ratio	5.60	-	4.37	-	-	3.94
EV/Sales Ratio	0.16	0.03	0.19	0.37	2.53	0.33
EV/FCF Ratio	2.48	-	2.17	-	-	4.00
Debt / Equity Ratio	-	-3.86	0.06	0.06	0.44	-0.45
Debt / FCF Ratio	-	-	0.10	-	-	0.86
Asset Turnover	2.28	2.37	2.29	1.64	1.41	2.11
Inventory Turnover	5.92	5.34	5.70	12.64	56.27	9.29
Quick Ratio	0.64	0.48	0.77	0.88	1.09	0.41
Current Ratio	0.93	0.92	1.33	1.65	1.42	0.60
Return on Equity (ROE)	-219.71%	-232.45%	-45.98%	-64.81%	-969.68%	-
Return on Assets (ROA)	-26.03%	-35.35%	-16.93%	-17.34%	-84.08%	-59.25%
Return on Capital (ROIC)	-143.14%	-161.92%	-39.30%	-33.05%	-281.25%	-529.73%
Earnings Yield	-51.19%	-85.80%	-21.40%	-23.86%	-33.26%	-112.58%
FCF Yield	17.14%	-30.41%	22.35%	-19.86%	-32.59%	25.40%
Buyback Yield / Dilution	-11.39%	-2.51%	-0.12%	-78.93%	-22.44%	-258.03%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.